News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Arrhythmia Research Technology, Inc. (HRT) Names New CEO


4/12/2013 9:09:19 AM

Arrythmia names Salvatore Emma, Jr. CEO of the Fitchburg, Mass.-based medical device company. Arrythmia Research Technology (NYSE:HRT) said on April 9 that Salvatore Emma, Jr. has been named president and CEO of the Fitchburg, Mass.-based medical device company. He was also appointed to the company's board of directors.

Read at MassDevice

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES